Utilize the patient-derived xenograft for drug response profiling and biomarker discovery of immuno-oncology drug candidates.
This rodent model, engrafted with patient-derived tumor tissue and propagated lymphocytes, could be employed to test medicines in the tumor immune microenvironment. Source